0001127602-14-016878.txt : 20140508 0001127602-14-016878.hdr.sgml : 20140508 20140508192006 ACCESSION NUMBER: 0001127602-14-016878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140506 FILED AS OF DATE: 20140508 DATE AS OF CHANGE: 20140508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAY RUSSELL T CENTRAL INDEX KEY: 0001225960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 14826629 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-05-06 0000850693 ALLERGAN INC AGN 0001225960 RAY RUSSELL T 2525 DUPONT DRIVE IRVINE CA 92612 1 Common Stock 2014-05-06 4 A 0 1249 0 A 27167 D Nonemployee Director Stock Option (Right to Buy) 166.32 2014-05-06 4 A 0 4305 166.32 A 2024-05-06 Common Stock 4305 4305 D Represents shares of the Issuer's common stock underlying RSUs awarded to the Reporting Person. The RSUs will vest in full upon the earlier to occur of (i) the first anniversary of the grant date, or (ii) the annual meeting during the calendar year following the grant date of the RSUs at which one or more members of the Issuer's board of directors is standing for re-election, provided the Reporting Person remains in the Issuer's service on such date. The RSUs may vest earlier on an accelerated basis in the event of the Reporting Person's termination of service due to death or disability. The shares of the Issuer's common stock underlying the RSUs will be issued to the Reporting Person no later than ten (10) business days after the RSUs vest. Includes shares acquired pursuant to dividend equivalent rights attached to RSU previously granted to the Reporting Person. The per share exercise price is the closing price of Allergan's common stock as of the date of grant. Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the first stockholder meeting held in 2015 at which one or more members of the board are standing for re-election. /s/ Matthew J. Maletta, Attorney-in-Fact for Russell T. Ray 2014-05-08